Kymera Therapeutics Director Bruce Booth Liquidates $34.8 Million Stake Amid Stock Surge
Bruce Booth, a director at Kymera Therapeutics, Inc. (NASDAQ: KYMR), executed a substantial sale of 276,684 shares of common stock on June 25, 2026, realizing an aggregate value of $34,812,908. This transaction occurred against a backdrop of significant stock price appreciation, with shares gaining 155% over the past year and nearly 29% in the week…